Publication:
Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions

dc.contributor.buuauthorUsta, Mehmet
dc.contributor.buuauthorDilek, Kamil
dc.contributor.buuauthorYavuz, Mahmut
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.buuauthorGüllülü, Mustafa
dc.contributor.buuauthorYurtkuran, Mustafa Abbas
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0710-0923
dc.contributor.researcheridAAH-5054-2021
dc.contributor.scopusid7005030712
dc.contributor.scopusid56005080200
dc.contributor.scopusid7006244754
dc.contributor.scopusid35612977100
dc.contributor.scopusid6602684544
dc.contributor.scopusid7003389525
dc.date.accessioned2021-12-01T07:58:29Z
dc.date.available2021-12-01T07:58:29Z
dc.date.issued2001-03
dc.identifier.citationUsta, M. vd. (2001). "Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions". Clinical Nephrology, 55(3), 260-262.
dc.identifier.endpage262
dc.identifier.issn0301-0430
dc.identifier.issue3
dc.identifier.pubmed11316250
dc.identifier.scopus2-s2.0-0035105081
dc.identifier.startpage260
dc.identifier.urihttp://hdl.handle.net/11452/22919
dc.identifier.volume55
dc.identifier.wos000172184000014
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherDustri
dc.relation.journalClinical Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectConverting
dc.subjectEnzyme
dc.subjectInhibitor
dc.subjectUrology & nephrology
dc.subject.emtreeRenin
dc.subject.emtreeAngiotensin
dc.subject.emtreeAngiotensin 2 receptor antagonist
dc.subject.emtreeDipeptidyl carboxypeptidase inhibitor
dc.subject.emtreeEnalapril
dc.subject.emtreeLosartan
dc.subject.emtreeDrug effect
dc.subject.emtreeAdult
dc.subject.emtreeAlport syndrome
dc.subject.emtreeClinical article
dc.subject.emtreeControlled study
dc.subject.emtreeDiabetic nephropathy
dc.subject.emtreeGlomerulonephritis
dc.subject.emtreeDrug selectivity
dc.subject.emtreeDrug specificity
dc.subject.emtreeEssential hypertension
dc.subject.emtreeFemale
dc.subject.emtreeFocal glomerulosclerosis
dc.subject.emtreeGlomerulopathy
dc.subject.emtreeGlomerulosclerosis
dc.subject.emtreeMembranous glomerulonephritis
dc.subject.emtreeGlomerulus filtration
dc.subject.emtreeGlomerulus filtration rate
dc.subject.emtreeImmunoglobulin A nephropathy
dc.subject.emtreeHuman
dc.subject.emtreeHistopathology
dc.subject.emtreeImmunosuppressive treatment
dc.subject.emtreeKidney biopsy
dc.subject.emtreeKidney disease
dc.subject.emtreeKidney function
dc.subject.emtreeKidney plasma flow
dc.subject.emtreeLetter
dc.subject.emtreeMale
dc.subject.emtreeMembranoproliferative glomerulonephritis
dc.subject.emtreeProtection
dc.subject.emtreeProteinuria
dc.subject.emtreeRenin angiotensin aldosterone system
dc.subject.emtreeRisk factor
dc.subject.meshHumans
dc.subject.meshAntihypertensive agents
dc.subject.meshFemale
dc.subject.meshGlomerulonephritis
dc.subject.meshKidney glomerulus
dc.subject.meshLosartan
dc.subject.meshMale
dc.subject.meshProteinuria
dc.subject.meshReceptors, angiotensin
dc.subject.scopusRenin Angiotensin Aldosterone System; Angiotensin Receptor Antagonists; Diabetic Nephropathies
dc.subject.wosUrology & nephrology
dc.titleAnti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions
dc.typeLetter
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nefroloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: